Stay updated on Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial page.

Latest updates to the Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedA new Revision: v3.4.2 was added to the record history, and the previously listed notices for funding lapsed (Revision: v3.4.1) were removed.SummaryDifference0.5%

- Check20 days agoChange DetectedNotice about government funding and NIH Clinical Center status is displayed, and the page shows revision v3.4.1 replacing v3.4.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedThe page now includes a glossary toggle and green/red color-coding for additions and deletions in the revision history, and the revision label updated to v3.4.0.SummaryDifference0.6%

- Check42 days agoChange DetectedRevision: v3.3.4 was added to the page history, replacing the previous v3.3.3 entry.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history now shows a new Revision: v3.3.3 entry, and the HHS Vulnerability Disclosure footer link was removed. These are administrative UI/policy updates and do not modify trial records or core page content.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page history shows a new revision label v3.3.2 replacing the previous v3.2.0; no trial data or record details appear to be changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial page.